← Leaderboards
Jianhua Zhou
Tufts Medical Center
$2,696,964
Attributed
$2,696,964
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $497.2K · FY2005–24$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,696,964 · 6
By mechanism
R01$1,291,100 · 1
R43$552,200 · 1
R21$534,520 · 2
R03$319,144 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Rna Splicing”
- Rolf Apweiler · European Molecular Biology Laboratory$41,336,566
- Daniel H Geschwind · University Of California Los Angeles$31,650,067
- Stacey Gabriel · Massachusetts Institute Of Technology$30,450,662
- Brenton R Graveley · University Of Connecticut Sch Of Med/Dnt$30,235,936
- Adrian R Krainer · Cold Spring Harbor Laboratory$28,755,040
- George M Church · Harvard University (Medical School)$26,862,961
Research focus
Rna SplicingAlzheimer&AposGene ExpressionImmunoprecipitationMicroarray TechnologyLaboratory MouseBiological Signal TransductionTissue /Cell CultureDisease /Disorder ModelBeta LactamasePathologic ProcessDegenerative Motor System DiseaseDna Binding ProteinLaboratory RabbitMessenger RnaGreen Fluorescent ProteinsGenetically Modified AnimalsSmall Nuclear RibonucleoproteinsGene Deletion MutationProtein Structure FunctionMotor NeuronsNeuropharmacologyPhosphatase InhibitorProgressive Spinal Muscular Atrophy
Grant awards (15)
Treatment with hrVCP of ApoE4 genetic predisposition to AD by controlling complement mediated neuroinflammation$55,000
R43 · FY2024 · AG · contact PI
Inhibition of Complement Pathways with VCP As A Treatment For Alzheimer's Disease$497,200
R43 · FY2023 · AG · contact PI
Cell Based Assays for Compounds That Regulate Tau Exon 10 Splicing$162,500
R21 · FY2007 · NS · contact PI
Targeting Bcl-x splicing for cancer treatment$78,894
R03 · FY2007 · CA · contact PI
Targeting Bcl-x splicing for cancer treatment$81,250
R03 · FY2006 · CA · contact PI
SMN associated proteins and compounds for SMA therapy$272,350
R01 · FY2005 · NS
Compounds regulating BACE 1 splicing and activity$79,500
R03 · FY2005 · AG
SMN associated proteins and compounds for SMA therapy$272,350
R01 · FY2004 · NS
A cell base system for compounds regulating tau splicing$186,010
R21 · FY2004 · NS
Compounds regulating BACE 1 splicing and activity$79,500
R03 · FY2004 · AG
SMN associated proteins and compounds for SMA therapy$232,600
R01 · FY2003 · NS
A cell base system for compounds regulating tau splicing$186,010
R21 · FY2003 · NS
SMN associated proteins and compounds for SMA therapy$232,600
R01 · FY2002 · NS
SMN associated proteins and compounds for SMA therapy$276,007
R01 · FY2001 · NS
SMN associated proteins and compounds for SMA therapy$5,193
R01 · FY2001 · NS